ArticleCancer medicine2026

Final Efficacy and Safety Results of Pyrotinib Combined With Trastuzumab and Chemotherapy in Pre-Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer.

Xiaofeng Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.